Sign in

You're signed outSign in or to get full access.

Tolf Corman

Research Analyst at Craig-Hallum

Tol Kohrman (also known as Tolf Corman) is a Research Analyst at Craig-Hallum Capital Group LLC, specializing in healthcare and biotechnology sectors. He provides equity research coverage on companies in these areas, contributing to the firm's overall analyst performance with a firm-wide success rate of 49.41% and average return of 16.60% as ranked on TipRanks, though individual metrics are not separately detailed. Kohrman joined Craig-Hallum as a research analyst, with his career timeline reflecting current employment at the firm following prior experience not specified in available records. He holds FINRA broker registration (CRD# 7987563) as a regulated broker at the firm.

Tolf Corman's questions to InfuSystem Holdings (INFU) leadership

Question · Q4 2025

Tolf Corman inquired if InfuSystem is considering exiting any other low-margin businesses or pursuing additional opportunities to drive efficiency.

Answer

Carrie Lachance, Chief Executive Officer, stated that there are no other low-margin areas currently under consideration for exit. She added that the company will continue to optimize its Biomedical Services team to focus on regional work and profitable client engagements, rather than flying technicians nationwide unless pricing is favorable.

Ask follow-up questions

Fintool

Fintool can predict InfuSystem Holdings logo INFU's earnings beat/miss a week before the call